We demonstrated that topical application of rapamycin decreased the activation of the PI3K-mTOR cascade and normalized the expression of epidermal differentiation markers in imiquimod-induced psoriasiform dermatitis model in mice, suggesting the utility of rapamycin as a topical remedy for psoriasis [101,108]. Here, MTOR is linked to psoriasis.